Last update 01 Nov 2024

Lantu Biopharma Inc.

Private Company|
2020|
Guangdong Sheng, China

Overview

Tags

Other Diseases
Congenital Disorders
Nervous System Diseases
AAV based gene therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases2
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
AAV based gene therapy3
Top 5 TargetCount
SMN1(survival of motor neuron 1, telomeric)1
ATP7A(ATPase copper transporting alpha)1
β-globin(Hemoglobin beta chain)1

Related

3
Drugs associated with Lantu Biopharma Inc.
Vesemnogene Lantuparvovec
Target
SMN1
Mechanism
SMN1 modulators
Active Org.
Lantu Biopharma Inc.
Originator Org.
Lantu Biopharma Inc.
Active Indication
Spinal Muscular Atrophy
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
Vebeglogene Autotemcel
Target
β-globin
Mechanism
HBB gene modulators
Active Org.
Lantu Biopharma Inc.
Originator Org.
Lantu Biopharma Inc.
Active Indication
Beta-Thalassemia [+1]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
LTGT-06
Target
ATP7A
Mechanism
ATP7A modulators [+1]
Active Org.
Lantu Biopharma Inc.
Originator Org.
Lantu Biopharma Inc.
Active Indication
Menkes Kinky Hair Syndrome
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Lantu Biopharma Inc.
NCT06288230 / RecruitingPhase 1/2
Study of AAV-hSMN1 (Vesemnogene Lantuparvovec) Gene Therapy in Subjects with Progressive Spinal Muscular Atrophy
NCT06308159 / RecruitingPhase 1/2
An Open-label Clinical Trial of Ex Vivo Beta-globin Lentiviral Vector Transduction of Autologous CD34+HSPCs (Vebeglogene Autotemcel) for the Treatment of Transfusion Dependent Beta-thalassemia Patients
100 Clinical Results associated with Lantu Biopharma Inc.
Login to view more data
0 Patents (Medical) associated with Lantu Biopharma Inc.
Login to view more data
100 Deals associated with Lantu Biopharma Inc.
Login to view more data
100 Translational Medicine associated with Lantu Biopharma Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
2
Phase 2 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Vebeglogene Autotemcel
 ( β-globin )		Beta-Thalassemia
More
Phase 2 Clinical
Vesemnogene Lantuparvovec
 ( SMN1 )		Spinal Muscular Atrophy
More
Phase 2 Clinical
LTGT-06
 ( ATP7A )		Menkes Kinky Hair Syndrome
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free